News

Home News

25

Feb2020

Sharing Responses to the Patented Medicine Prices Review Board (PMPRB) Draft Guidelines Consultation

/ PDCI, PMPRB
On November 21, 2019, the PMPRB published its draft Guidelines and launched a public consultation as a step towards implementing ... Read More

24

Feb2020

Status Summary of Innovative Medicine pCPA Negotiations as of January 31, 2020

/ pCPA, What's New
Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of ... Read More

14

Feb2020

CADTH Releases Pharmaceutical Reviews Update – Issue 13

/ CADTH, PDCI, What's New
CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review process updates to the public. PDCI ... Read More

13

Feb2020

PDCI Analysis Estimates Impact of PMPRB Draft Guidelines to be up to $41.8 Billion

/ PDCI, PMPRB, Publications, What's New
Following the publication of the PMPRB Draft Guidelines on Nov 21, 2019, PDCI undertook an analysis to critically assess the ... Read More

14

Jan2020

PMPRB and “Zero-dollar” Sales

/ Blog, PDCI, PMPRB, What's New
W. Neil Palmer In its December 2019 NEWSletter[1], the Patented Medicine Prices Review Board (PMPRB) is “reminding” patentees that ... Read More

13

Jan2020

CADTH Releases Pharmaceutical Reviews Update – Issue 12

/ CADTH, What's New
CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review process updates to the public. ... Read More

06

Jan2020

PMPRB Consultation Update and Patentee Webinar

/ PMPRB
Recently, the deadline for providing written submissions on the PMPRB’s proposed new Guidelines was extended until January 31, 2020. As part ... Read More

10

Dec2019

Status Summary of Innovative Medicine pCPA Negotiations as of November 30, 2019

/ pCPA, What's New
Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of ... Read More